These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 16334365)
21. Competing for more attention. Nielsen, J.D. Power amp up healthcare offerings. Robeznieks A Mod Healthc; 2007 Aug; 37(34):24. PubMed ID: 17960696 [No Abstract] [Full Text] [Related]
22. Brand names invade the healthcare market. Perry L Mod Healthc; 1988 May; 18(21):22-4, 28-9. PubMed ID: 10287283 [No Abstract] [Full Text] [Related]
23. Patients and other publics. Hicks NJ Public Relat J; 1986 Mar; 42(3):28-32. PubMed ID: 10276979 [No Abstract] [Full Text] [Related]
24. Strategic planning for hospitals under regulation. Thieme CW; Wilson TE; Long DM Health Care Manage Rev; 1981; 6(2):35-43. PubMed ID: 7016812 [No Abstract] [Full Text] [Related]
26. Kickbacks, courtesies or cost-effectiveness?: Application of the Medicare antikickback Law to the marketing and promotional practices of drug and medical device manufacturers. Bulleit TN; Krause JH Food Drug Law J; 1999; 54(3):279-323. PubMed ID: 11797701 [TBL] [Abstract][Full Text] [Related]
27. Health care E-commerce and the Internet: ten strategies for health care providers and health plans doing business on the Web. Coile RC; Howe RC Russ Coiles Health Trends; 1999 Jul; 11(9):1, 3-8. PubMed ID: 10539460 [No Abstract] [Full Text] [Related]
28. The vexations of Vioxx. Sibbald B CMAJ; 2006 Feb; 174(4):444-5. PubMed ID: 16477046 [No Abstract] [Full Text] [Related]
30. Throughout the health sector: communication must influence and engage. Ratzan SC J Health Commun; 2006; 11(5):453-4. PubMed ID: 16846947 [No Abstract] [Full Text] [Related]
31. Anticipating a Vioxx defense strategy: will corporate honesty be enough? Willis KD Tort Trial Insur Pract Law J; 2006; 41(4):1163-78. PubMed ID: 17091567 [No Abstract] [Full Text] [Related]
33. Transparent communication strategy on GMOs: will it change public opinion? Sinemus K; Egelhofer M Biotechnol J; 2007 Sep; 2(9):1141-6. PubMed ID: 17703492 [TBL] [Abstract][Full Text] [Related]
35. Developing Medical Affairs Leaders Who Create the Future. Bedenkov A; Rajadhyaksha V; Beekman M; Moreno C; Fong PC; Agustin L; Odell S Pharmaceut Med; 2020 Oct; 34(5):301-307. PubMed ID: 32949352 [TBL] [Abstract][Full Text] [Related]
36. No one's safe from 'Enronitis'. A plague of corporate failures affects the healthcare industry, too. Peregrine M; Schwartz J Mod Healthc; 2002 Apr; 32(15):26. PubMed ID: 12001495 [No Abstract] [Full Text] [Related]
37. Clinical trials and tribulations. Allegations of waste: the 'seeding' study. Malakoff D Science; 2008 Oct; 322(5899):213. PubMed ID: 18845743 [No Abstract] [Full Text] [Related]
38. Immune to marketing? Med students say gifts won't influence them: study. Robeznieks A Mod Healthc; 2005 Sep; 35(38):52. PubMed ID: 16273715 [No Abstract] [Full Text] [Related]
39. Internet strategies being implemented by pharmaceutical companies. Goldstein D; Flory J Med Interface; 1997 May; 10(5):48-50. PubMed ID: 10167503 [No Abstract] [Full Text] [Related]
40. Dan S. Wilford: president and CEO emeritus, Memorial Hermann Healthcare System. Wilford DS Hosp Top; 2008; 86(1):29-31. PubMed ID: 18362091 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]